mTOR inhibitors are therefore considered a valuable addition to chemotherapy or targeted cancer therapy, either as an option for relapsed patients or as a frontline combination therapy to prevent or delay the development of resistance due to sustained mTOR signaling4,5. This evidence concerns the gene MTOR and cancer.